InvestorsObserver gives Abbott Laboratories (ABT) a weak valuation score of 16 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. ABT currently holds a better value than 16% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.
ABT gets a 16 Valuation Rank today. Find out what this means to you and get the rest of the rankings on ABT!
ABT has a trailing twelve month Price to Earnings (PE) ratio of 20.8. The historical average of roughly 15 shows a poor value for ABT stock as investors are paying higher share prices relative to the company's earnings. ABT's high trailing PE ratio shows that the firm has been trading above its fair market value recently. Its trailing 12-month earnings per share (EPS) of 4.79 does not justify the stock's current price. However, trailing PE ratios do not factor in the company's projected growth rate, resulting in many newer firms having high PE ratios due to high growth potential enticing investors despite inadequate earnings.
ABT currently has a 12-month-forward-PE-to-Growth (PEG) ratio of 3.73. The market is currently overvaluing ABT in relation to its projected growth due to the PEG ratio being above the fair market value of 1. ABT's PEG comes from its forward price to earnings ratio being divided by its growth rate. Because PEG ratios include more fundamentals of a company's overall health with additional focus on the future, they are one of the most used valuation metrics by analysts.
Summary
ABT' has a weak valuation at its current share price on account of a overvalued PEG ratio due to strong growth. ABT's PE and PEG are worse than the market average leading to a below average valuation score.
Click Here to get the full Report on Abbott Laboratories (ABT) stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
